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Objective: Hypoxemia is known to be associated with abnormal heart rate
variability (HRV) that can reflect the severity of the illness and may have prognostic
value in patients with chronic obstructive pulmonary disease (COPD). The aim of this
study was to examine the relationship between the derangements in cardiac
autonomic nervous function and the oxygenation status or degree of airflow
obstruction in COPD patients by using HRV analysis.
Methods: Thirty clinically stable COPD patients and 18 age-matched normal
subjects were included in this study. The normalized high-frequency power (nHFP)
and the low-/high-frequency power ratio (LFP/HFP) were used as indices of vagal
activity and sympathovagal balance, respectively.
Results: Although global HRV measures were all significantly decreased, the nHFP
and LFP/HFP of COPD patients were not significantly different from those of normal
controls. There was a negative correlation between nHFP and arterial partial
pressure of O2 (PaO2) and a positive correlation between LFP/HFP and PaO2 in COPD
patients. No correlation existed between forced expiratory volume in 1.0 s/forced
vital capacity (FEV1/FVC), % predicted of FEV1 (%FEV1) and nHFP or LFP/HFP in COPD
patients.
Conclusions: The resting autonomic nervous function of COPD patients is not
different from that of normal controls. Though the degree of airway narrowing is notElsevier Ltd. All rights reserved.
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enhanced cardiac vagal activity and depressed sympathetic activity in COPD
patients. A worse oxygenation status is associated with increased cardiac vagal
and decreased cardiac sympathetic activities in COPD patients.
& 2006 Elsevier Ltd. All rights reserved.Introduction
The autonomic innervations of human airway have
parasympathetic cholinergic, sympathetic adrener-
gic and peptidergic efferent components.1,2 The
imbalance in the autonomic nervous activity can
contribute to airway narrowing via its effect on the
airway smooth muscle, bronchial vessels and
mucous glands in the bronchial wall.1,2 By using
the maximum increase in forced expiratory volume
in 1.0 s (FEV1) following administration of an
optimal dose of an anticholinergic agent atropine
methionitrate as the index of the amount of
cholinergic tone, Gross et al.3 showed that choli-
nergic tone in chronic obstructive pulmonary
disease (COPD) was increased in proportion to the
severity of airway disease. It is therefore likely that
abnormal activity of autonomic nerves innervations
can contribute to airway narrowing in COPD, and
may be relevant to the pathogenesis of COPD.
Unfortunately, the actual tone of the airways is
difficulty to detect non-invasively.
Heart rate variability (HRV) refers to the beat-to-
beat alterations in heart rate. It can offer a
quantitative assessment of the cardiac autonomic
nervous activity and the level of physical fitness.4 In
many basic and clinical studies, the HRV has been
used to reflect not only the cardiac autonomic
nervous activity, but also the severity of cardiac
and non-cardiac diseases.4–6 The major reason for
the interest in measuring HRV stems from its ability
to predict survival after heart attack and the
prognosis of many major diseases.4–6
By using spectral HRV analysis, Volterrani et al.7
found that COPD patients had abnormal autonomic
nervous function, with, in particular, a depressed
HRV response to sympathetic and vagal stimuli.
They interpreted the increase in the normalized
high-frequency power (nHFP) in COPD patients as
caused by an increase in vagal activity which could
in turn explain in part the reduction in FEV1 and the
increase in bronchoconstriction seen in COPD
patients; however, the relation between vagal
activity and the severity of airway disease was
not shown in their study. In the study of Stein et
al.,8 though significantly positive correlation be-
tween FEV1 and log(HFP) was found in COPD
patients, the nHFP and low-/high-frequency powerratio (LFP/HFP), which were often used as indices
of vagal modulation and sympathovagal balance,
respectively,4 were not included.
Stewart et al.9–11 and Hjalmarsen et al.12 found
that the patients with hypoxemic COPD have a
subclinical parasympathetic autonomic neuropathy,
with apparent preservation of sympathetic func-
tion. Moreover, Steward et al. found that the
autonomic neuropathy correlated significantly with
arterial partial pressure of O2 (PaO2) in COPD
patients, based on standard autonomic function
tests9 and acetylcholine sweat-spot test.10 By using
spectral HRV analysis, Scalvini et al.13 found that
chronically hypoxemic COPD patients may suffer
from abnormal autonomic nervous function and the
correction of hypoxemia can partially reverse these
abnormalities. It remains to be clarified whether
the sympathetic or parasympathetic function of the
subjects is correlated with their PaO2 in COPD
patients. Therefore, the aim of this study was to
examine the relationship between the derange-
ments in the cardiac autonomic nervous function
and the oxygenation status or degree of airflow
obstruction in COPD patients by using HRV analysis.Methods
Study subjects
The COPD patients included in this study were
clinically stable and ambulatory, and were re-
cruited from the Out-Patient Department of
the hospital. COPD was defined according to the
criteria of the American Thoracic Society.14 The
aged-matched normal subjects were volunteers
recruited from the community. The subjects in-
cluded in the normal group did not have apparent
cardiac, lung or other major diseases that may
influence HRV.
Study protocol
On the day of HRV study, the morning doses of
aminophylline, b2-agonists and steroid were re-
quested to skip, and this status of no medication
lasted for about 6 h prior to electrocardiographic
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would not be too strong to interfere with the result
of HRV analysis or too weak to elicit bronchocon-
strictive episode. It may not be ethical to dis-
continue the medication of the patients for 24 h or
longer simply because of study. The Institutional
Review Board of the hospital has approved this
research. Informed consent was obtained from
each patient before study.Physiological measurements
All subjects were studied in a quiet air-conditioned
room with constant temperature around 25 1C and
suitable humidity. After 5min rest in supine
position, a trend of ECG signals was picked up by
a bedside ECG monitor (SpaceLab 90621A Monitor,
Spacelabs Inc., Redmond, WA) and transmitted to a
personal computer for recording. During the re-
cording period, the subjects were asked to close
their eyes and relax on the bed. The ECG signals
were recorded for 15min so that at least 512 RR
intervals could be obtained for later HRV analysis.
After ECG recording, the forced expiratory
volume in the 1.0 s/forced vital capacity (FEV1/
FVC) of ordinary pulmonary function test (Spirovit
SP-10, Schiller, Switzerland), arterial oxygen sa-
turation from pulse oximetry (SpO2) (BCI 6100 Vital
Signs Monitor, Biochem International Inc., Wiscon-
sin) and PaO2 from arterial blood gases (Automatic
Blood Gas System AVL 945, Bedienungs Anleitung,
Graz-Austria) were obtained along with other
clinical information necessary for the evaluation
of the severity of the illness. Arterial puncture was
performed on COPD patients only. The FEV1/FVC
and % predicted of FEV1 (%FEV1) were used as the
indices for the evaluation airflow obstruction. PaO2
was used to represent the oxygenation status of
COPD patients, and SpO2 was used to represent the
oxygenation status of normal subjects.HRV analysis
The method of HRV analysis was modified from our
previous study.15 In brief, the recorded ECG signals
were retrieved to measure the consecutive RR
intervals, which are the time intervals between
successive pairs of QRS complexes, by using the
software for the detection of R waves. The atrial or
ventricular arrhythmia was deleted before HRV
analysis. If the percentage of deletion was more
than 5%, then the data of the patient was excluded
from HRV analysis.
The mean, standard deviation (SDRR) and coeffi-
cient of variation of RR intervals (CVRR ¼ SDRR/meanRR interval) in the time domain of 512 RR intervals
were calculated by using standard formulae. The
power spectrum of these RR intervals was obtained
by means of fast Fourier transformation (Mathcad
11, Mathsoft Inc., Cambridge, MA). Zero-frequency
component or direct current was excluded before
the calculation of the powers. The frequency at
which the high-frequency peak occurred (HFF) was
used as the breathing frequency of the subject. The
area under the spectral peaks within the range of
0.04–0.15, 0.15–0.4, and 0.01–0.4Hz were defined
as the low-frequency power (LFP), HFP, and total
power (TP). The normalized HFP (nHFP ¼ HFP/TP)
was used as the index of vagal activity, the
normalized LFP (nLFP ¼ LFP/TP) as the index of
combined vagal and sympathetic activities, and the
LFP/HFP as the index of sympathovagal balance.
Statistical analysis
Unpaired Student t-test or Mann–Whitney rank sum
test (SigmaStat 3.0 statistical software, SPSS Inc.,
Chicago, IL, USA) was employed to compare the
normally distributed or distribution-free clinical
data and HRV measures between normal subjects
and COPD patients. Linear regression analysis was
employed to assess the relationships between HRV
measures and PaO2, SpO2, FEV1/FVC, %FEV1, or
%FVC (% predicted of FVC).Results
Thirty clinically stable ambulatory COPD patients
and 18 age-matched normal subjects were included
in this study. The general and clinical data of
normal subjects and COPD patients are shown in
Table 1. The FEV1, FEV1/FVC, %FEV1, %FVC, and
SpO2 of COPD patients were all significantly
decreased as compared with those of normal
subjects.
Table 2 tabulates the HRV measures of normal
subjects and COPD patients. The mean, SDRR and
CVRR in the time domain and the TP, LFP and HFP in
the frequency domain were all significantly de-
creased, whereas the HFF was significantly in-
creased in COPD patients, as compared with normal
subjects. In contrast, the nHFP, nLFP and LFP/HFP
were not significantly different between normal
subjects and COPD patients.
The nHFP correlated significantly and negatively
with PaO2 (Fig. 1, panel A), and the nLFP (Fig. 1,
panel B) and LFP/HFP (Fig. 1, panel C) correlated
significantly and positively with PaO2 in COPD
patients. These spectral HRV measures did not
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FEV1/FVC (Fig. 1, panels D–F) in COPD patients.
Similarly, no correlation was found between %FEV1
and spectral HRV measures, including nHFP
(r ¼ 0:0984, P ¼ 0:605), nLFP (r ¼ 0:0516,
P ¼ 0:787), and LFP/HFP (r ¼ 0:0095, P ¼ 0:96).Discussion
Stewart et al.9–11 and Hjalmarsen et al.12 have
shown that subclinical parasympathetic autonomic
neuropathy was a feature of hypoxemic COPD.
Since the results of Stewart et al.9–11 and Hjalmar-Table 1 General and clinical data of normal
subjects and COPD patients.
Normal ðn ¼ 18Þ COPD ðn ¼ 30Þ
Age (years) 64.879.0 69.676.5
Sex (M/F) 15/3 25/5
Body height (cm) 163.076.4 163.579.3
Body weight (kg) 63.379.1 64.0713.2
FEV1 (L) 2.270.4 1.370.6
z
FEV1/FVC (%) 78.378.7 50.2711.0
z
% FEV1 (% pred) 102.1714.3 50.5719.9
z
%FVC (% pred) 106.1721.9 82.7720.2y
SpO2 (%) 96.571.2 95.372.3
*
pH 7.43870.040
PaO2 (mmHg) 79.4711.8
PaCO2 (mmHg) 38.474.5
HCO3
 (mmol/L) 26.974.4
Values are mean7SD. FEV1.0, forced expiratory volume in
1.0 s; FVC, forced vital capacity; % FEV1, % predicted of
FEV1; %FVC, % predicted of FVC; SpO2, arterial oxygen
saturation measured by pulse oximetry; *Po0.05,
yPo0.01, zPo0.001 (unpaired Student t-test or Man-
n–Whitney rank sum test).
Table 2 Heart rate variability measures in normal subje
Normal ðn ¼ 18Þ
Mn (ms) 917.9 (832.4–1005
SDRR (ms) 36.2 (28.0–43.8)
CVRR (%) 4.25 (3.10–4.50
TP (ms2) 648.2 (355.6–971.
LFP (ms2) 114.5 (53.2–176.8
HFP (ms2) 121.9 (38.4–208.3
HFF (Hz) 0.25 (0.23–0.28
nLFP (nu) 16.9 (12.9–22.6)
nHFP (nu) 18.5 (11.0–23.1)
LFP/HFP 1.0 (0.7–1.4)
Values are median (25–75%). Mn, mean RR interval; SDRR, standard
interval; TP, total power; LFP, low-frequency power; HFP, high-fre
normalized low-frequency power; nHFP, normalized high-freq
yPo0.01, zPo0.001 (Mann–Whitney rank sum test).sen et al.12 were obtained by using the sympathetic
and parasympathetic stimulation method of Ewing
and Clarke,16 the autonomic nervous function of
the COPD patients at rest was not clear from their
studies. By using HRV analysis, Volterrani et al.7
found that COPD patients had depressed global HRV
and increased nHFP at rest. They interpreted the
increase in nHFP in COPD patients as caused by an
increase in vagal activity that could in turn explain
in part the reduction in FEV1 and the increase in
bronchoconstriction seen in COPD patients. In the
reports of Stein et al.8 and Scalvini et al.,13 some
indices of HRV mediated by parasympathetic tone
or by both sympathetic and parasympathetic tone
in COPD patients were found to be lower than those
of the control subjects. In the present study, we
found that although global HRV measures were all
significantly decreased, the nHFP, nLFP and LFP/
HFP of the COPD patients were not significantly
different from those of the control subjects. Our
observation suggested that both vagal and sympa-
thetic modulations of stable COPD patients at rest
were similar to those of normal controls. However,
this observation should not be interpreted as no
autonomic neuropathy in COPD patients because
we did not perform sympathetic and parasympa-
thetic stimulation test in this study. That is, though
the resting autonomic nervous activity of the stable
COPD patients was similar to that of normal
subjects, they might still have abnormal response
to sympathetic and parasympathetic stimulation
test.
Several reasons might account for the difference
between our finding of normal resting autonomic
nervous activity and elevated vagal activity in
COPD patients in the study of Volterrani et al.
Firstly, since the age of the patients in the study of
Volterrani et al. was 31–68 years, some of theircts and COPD patients.
COPD ðn ¼ 30Þ
.0) 694.3 (617.3–738.0)z
13.8 (10.8–23.1)z
) 2.20 (1.90–3.10)z
7) 90.1 (39.6–257.5)z
) 14.2 (4.7–44.9)z
) 13.0 (4.6–30.2)z
) 0.32 (0.26–0.35)y
14.6 (11.0–28.7)
17.0 (7.3–25.1)
1.3 (0.4–3.0)
deviation of RR interval; CVRR, coefficient of variation of RR
quency power; HFF, frequency of high-frequency peak; nLFP,
uency power; LFP/HFP, low-/high-frequency power ratio.
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Figure 1 The normalized high-frequency power (nHFP) correlated significantly and negatively with PaO2 (panel A), and
the normalized low-frequency power (nLFP) (panel B) and low-/high-frequency power ratio (LFP/HFP) (panel C)
correlated significantly and positively with the PaO2 in COPD patients. There was no correlation between FEV1/FVC and
nHFP (panel D), nLFP (panel E) or LFP/HFP (panel F).
Hypoxemia and autonomic nervous dysfunction in COPD 1551young patients might be asthmatic patients rather
than COPD, and asthmatics were already known to
have vagal overactivity.17 Secondly, the study of
Volterrani et al. was performed in the morning
after discontinuing the treatment with aminophyl-
line, oral b2-agonist and steroid medications for
24 h, whereas we performed the study in the
afternoon and the medical treatment was discon-
tinued for less than 24 h. The discontinuation of
medical treatment for 24 h might cause rebound
vagal overactivity in those patients who had been
using aminophylline, oral b2-agonist and steroid
medications as maintenance therapy for a long
period of time. Thirdly, the frequency range for the
HFP was 0.18–0.35Hz in the study of Volterrani et
al., whereas the frequency range for the HFP in this
study was 0.15–0.4 Hz. Different frequency range
might lead to different values for the HFP and nHFP.
Similar to the studies of Stein et al.8 and Scalvini
et al.,13 we found that there were significant
differences in TP, LFP, and HFP between COPDpatients and control subjects. However, we found
that the nHFP, nLFP, and LFP/HFP of COPD patients
were not significantly different from those of the
control subjects. The representation of LFP and
HFP in normalized units emphasizes the controlled
and balanced behavior of the two branches of the
autonomic nervous system, while the normalization
procedure tends to minimize the effect of the
changes in TP on the values of LFP and HFP
components.4 Though there was a significant
difference in LFP and HFP between COPD patients
and control subjects, this result may not be
interpreted as significant autonomic dysfunction
in resting stable COPD patients because no sig-
nificant difference in nLFP and nHFP was found
between these two groups of subjects.
Stewart et al.9 found that the degree of para-
sympathetic autonomic dysfunction correlated
significantly with PaO2 whilst the sympathetic func-
tion was relatively normal in COPD patients. By
measuring the pancreatic polypeptide, Hjalmarsen
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pancreatic polypeptide was increased and had a
significant negative correlation with FEV1, SaO2 and
PaO2 in COPD patients. These studies suggested
that the vagal activity of COPD patients was related
to the oxygenation status of the patients. Similarly,
we found that the index of vagal activity of COPD
patients correlated significantly and negatively
with PaO2, and the index of sympathetic activity
correlated significantly and positively with PaO2.
However, both indices of autonomic nervous activ-
ity and PaO2 did not correlate with either FEV1/FVC
or %FEV1 in COPD patients.
The high metabolic activity of nerves makes
them extremely susceptible to hypoxemia and
could cause a reversible impairment in electro-
physiological function.9 Since the SpO2 of our COPD
patients was significantly lower than that of normal
control (Table 1), it seemed possible that chronic,
mild hypoxemia might cause hypoxic damage to the
nerve which in turn could lead to increased cardiac
vagal activity and decreased sympathetic activity
in stable but chronically hypoxemic COPD pa-
tients.9–12
One might speculate that the negative correla-
tion between nHFP and PaO2 in COPD patients could
be caused by respiration-related mechanism, be-
cause hypoxemia can lead to hyperventilation and
because the amplitude of the high-frequency
component can be significantly affected by respira-
tory frequency and tidal volume independent of the
level of cardiac vagal outflow.18–21 Since no
correlation was found between PaCO2 and nHFP in
this study, it was unlikely that the correlation
between nHFP and PaO2 was caused by respiration-
related mechanism in COPD patients.
The cholinergic tone in COPD patients was shown
to be increased in proportion to the severity of
airway disease.3 In addition, significant correlations
were found between FEV1/FVC and some indices of
HRV (natural log of LFP and HFP) in the study of
Stein and associates.8 However, we found that
FEV1/FVC and %FEV1 did not correlate significantly
with the indices of autonomic nervous function
(nLFP, nHFP and LFP/HFP) in COPD patients. The
representation of LFP and HFP in normalized units
might account for the difference between the
results of the present study and the study of Stein
et al. The reason for no significant correlation
between HRV measures and FEV1/FVC or %FEV1 in
this study might be that HRV might not reflect the
actual tone of the airway in COPD patients.
The HRV can be influenced by the circadian
rhythm,22 the medication, and the respiration rate
of the patients. To minimize the potential impact of
circadian rhythm HRV, the ECG signals of allsubjects were picked up at 3–4 p.m. in this study.
The insufficient duration of discontinuation of
sympathomimetic medication taken by the patients
might have some effect on their HRV. However, the
sympathomimetic agents of the patients might not
be a problem because: (1) The duration of
discontinuation of sympathomimetic agents was in
fact longer than 12 h; (2) The increase in heart rate
and respiratory rate in our patients might be
caused by not only sympathomimetic agents, but
also the disease itself, such as airway obstruction
and hypoxemia; (3) The effect of heart rate on the
time domain HRV measures can be minimized by
using CVRR which is the SDRR divided by mean RRI,
and the effect of heart rate on frequency domain
HRV measures can be minimized by excluding the
zero-frequency component or direct current or
mean RRI before the calculation of the powers by
using Fast Fourier Transform.
Though there was a significant difference in HFF
(0.2670.04 vs. 0.3070.06Hz [mean7SD], Po0.01)
between normal subjects and COPD patients, we
did not try to control and adjust the respiratory
rate of the patients to that of normal subjects
because such maneuver would inevitably interfere
with the autonomic nervous system of the patients,
leading to unreal and biased HRV. If the patients
had slight tachypnea because of airway obstruction
and hypoxemia, it would be more natural to record
and analyze the rhythm of their heart beating as
they really were. This was the reason why we made
no attempt to control the respiratory rate of the
COPD patients in this study.
In conclusion, the resting autonomic nervous
function of COPD patients is not significantly
different from that of normal subjects. The degree
of airway narrowing is not directly related to the
cardiac autonomic nervous function; however,
chronic hypoxemia can increase the cardiac vagal
activity and depress the sympathetic activity of
COPD patients. The worse the oxygenation status of
the patients is, the more cardiac vagal and lesser
cardiac sympathetic activities the patients have.Acknowledgments
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